{"version":"1.0","type":"link","title":"Exposure-Response Analysis of Repotrectinib to Support the Dose Recommendation for Patients With ROS1-Positive NSCLC or NTRK-Positive Solid Tumors.","author_name":"Du S 외","author_url":"https://prs-insight.online/author/Du%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/101331","thumbnail_width":1200,"thumbnail_height":630}